A Novel Oral Vehicle for Poorly Soluble HSV-Helicase Inhibitors: PK/PD Validations

Author： Duan Jianmin   Liard Francine   Paris William   Lambert Michelle  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.21, Iss.11, 2004-11, pp. : 2079-2084

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Helicase-primase inhibitors promising in HSV infection

By  

Inpharma, Vol. 1, Iss. 1337, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Translational PK-PD modeling in pain

By Yassen Ashraf  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 401-418

Springer Publishing Company

Access to resources Recommend Favorite

Streamlining the PK/PD data transfer process

By Collins Arthur  

Pharmaceutical Programming, Vol. 3, Iss. 1, 2010-06 ,pp. : 24-28

Maney Publishing

Access to resources Recommend Favorite

Sample Size Computations for PK/PD Population Models

By Kang Dongwoo   Schwartz Janice   Verotta Davide  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 5-6, 2005-12 ,pp. : 685-701

Springer Publishing Company

Access to resources Recommend Favorite

A Bayesian Approach for PK/PD Modeling with PD Data Below Limit of Quantification

By Zhou Huafeng  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1220-1243

Taylor & Francis Ltd

Access to resources Recommend Favorite